Delivery Order SPE2DR25D2018-SPE2DR26FZ1E7
Award Date 2/9/26
Potential Completion Date 3/3/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $20,878.16. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 19, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tavalisse 150 mg tablets (60-count) with a contract ceiling value of $18,593.94. This competitively awarded, non-set-aside delivery order utilizes firm fixed price pricing and is scheduled for completion by October 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tavalisse 100 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $18,533.40 and an ultimate completion date of August 12, 2025. The award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. Tavalisse is a pharmaceutical product used in the...
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 60 tablets of Tavalisse 100 mg, a pharmaceutical product for immune thrombocytopenia treatment. The contract, which is a child order under a larger indefinite delivery vehicle, requires completion by November 19, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency Troop Support Medical awarded a $8,257.25 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561453025 TAVALISSE 150 MG TABLET 60S. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 10, 2023 through July 31, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply pharmaceutical products in support of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $10,439.07 to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on January 2, 2026, with completion expected by January 26, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tavalisse is an immunosuppressant medication used to treat immune thrombocytopenia, a blood disorder affecting...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $18,533.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the awardee's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $9,266.70. This firm fixed-price delivery order, due for completion by September 23, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DR25D2018Indefinite Delivery Contract
- SPE2DR25D2018-SPE2DR26FZ1E7Delivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $10,439.07 for TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. Place of performance is Conshohocken, PA 19428. The order is firm fixed price with an ultimate completion date of March 3, 2026. The delivery order was issued under the parent DLA Troop Support Medical indefinite delivery contract (SPE2DX), a global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026 that enables supply of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Generated 5/10/26, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 2/8/26 |